In newly diagnosed acute myeloid leukaemia (AML) patients, bone marrow lactate levels positively correlate with STAT molecule expression, lactylation levels in cancer cells, and PD‐L1 expression, suggesting that AML patients with high bone marrow lactate levels might benefit more from immunotherapy.108. This evidence concerns the gene CD274 and acute myeloid leukemia.